Citation: S. Nelson et Wr. Summer, INNATE IMMUNITY, CYTOKINES, AND PULMONARY HOST-DEFENSE, Infectious disease clinics of North America, 12(3), 1998, pp. 555
Citation: Tm. File et al., THE ROLE OF ATYPICAL PATHOGENS - MYCOPLASMA-PNEUMONIAE, CHLAMYDIA-PNEUMONIAE, AND LEGIONELLA-PNEUMOPHILA IN RESPIRATORY-INFECTION, Infectious disease clinics of North America, 12(3), 1998, pp. 569
Citation: De. Low, RESISTANCE ISSUES AND TREATMENT IMPLICATIONS - PNEUMOCOCCUS, STAPHYLOCOCCUS-AUREUS, AND GRAM-NEGATIVE RODS, Infectious disease clinics of North America, 12(3), 1998, pp. 613
Citation: Jf. Plouffe et al., VALUE OF NONINVASIVE STUDIES IN COMMUNITY-ACQUIRED PNEUMONIA, Infectious disease clinics of North America, 12(3), 1998, pp. 689
Citation: A. Torres et M. Elebiary, INVASIVE DIAGNOSTIC-TECHNIQUES FOR PNEUMONIA - PROTECTED SPECIMEN BRUSH, BRONCHOALVEOLAR LAVAGE, AND LUNG-BIOPSY METHODS, Infectious disease clinics of North America, 12(3), 1998, pp. 701
Citation: Tj. Marrie, COMMUNITY-ACQUIRED PNEUMONIA - EPIDEMIOLOGY, ETIOLOGY, TREATMENT, Infectious disease clinics of North America, 12(3), 1998, pp. 723
Citation: Te. Auble et al., ASSESSING PROGNOSIS AND SELECTING AN INITIAL SITE OF CARE FOR ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA, Infectious disease clinics of North America, 12(3), 1998, pp. 741
Citation: R. Mceachern et Gd. Campbell, HOSPITAL-ACQUIRED PNEUMONIA - EPIDEMIOLOGY, ETIOLOGY, AND TREATMENT, Infectious disease clinics of North America, 12(3), 1998, pp. 761
Citation: Ba. Collin et R. Ramphal, PNEUMONIA IN THE COMPROMISED HOST INCLUDING CANCER-PATIENTS AND TRANSPLANT PATIENTS, Infectious disease clinics of North America, 12(3), 1998, pp. 781
Citation: Kc. Kain et Js. Keystone, MALARIA IN TRAVELERS - EPIDEMIOLOGY, DISEASE, AND PREVENTION, Infectious disease clinics of North America, 12(2), 1998, pp. 267
Citation: Cd. Ericsson, TRAVELERS DIARRHEA - EPIDEMIOLOGY, PREVENTION, AND SELF-TREATMENT, Infectious disease clinics of North America, 12(2), 1998, pp. 285